A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs ...

The dosing of these two patients demonstrates Cellares’ GMP manufacturing and supply chain capabilities with their automated platform.

Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for ...

A stem cell therapy with potential disease-modifying effects for feline osteoarthritis (OA) is underway.

In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...

Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.

High co-payments for potentially curative cell and gene therapies create avoidable access barriers; value-based insurance ...

Chimeric antigen receptor T-cell therapy (CAR T) has revolutionized oncology treatment over the last decade, offering targeted therapy options for several difficult cancers, espec ...

CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...

The combined company will trade on the Nasdaq under the ticker OBX. It has also secured commitments for a private placement ...

Frailty is not a single disease with a single cause: it arises from the effects of chronic inflammation, muscle loss, ...

New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...